Conference Coverage
Conference Coverage
Collaborative cancer care cuts readmission rates
while another looks on Credit: NCI A “co-rounding” partnership between medical oncologists and palliative care specialists has shown improvements...
Conference Coverage
New drug boosts survival in metastatic CRC
Key clinical point: TAS-102 treatment significantly boosted overall survival with good tolerability in patients with metastatic colorectal cancer...
Conference Coverage
Biomarker predicts bone loss in premenopausal breast cancer patients
Key clinical point: A premenopausal breast cancer patient’s FSH level upon completion of adjuvant chemotherapy identifies whether she ought to be...
Conference Coverage
Cancer treatment during pregnancy can be safe
At a median age of 6, most of the children exposed to radiation in utero had neuropsychological, behavioral, and general health outcomes that were...
Conference Coverage
Targeting drug resistance earlier
Credit: PNAS PHILADELPHIA—A combination treatment strategy that takes tumor evolution into account could help us avoid drug resistance in...
Conference Coverage
Veterans at increased risk of skin cancer
Key clinical point: Skin cancer prevention can be improved among U.S.
Conference Coverage
VIDEO: CLEOPATRA combo extends survival in HER2-positive metastatic breast cancer
Key clinical point: CLEOPATRA establishes pertuzumab and trastuzumab plus chemotherapy as the standard of care in metastatic HER2-positive breast...
Conference Coverage
Combo shows potential as frontline therapy in PTCL
Credit: NIH MADRID—Follow-up data from a phase 1 trial suggest brentuximab vedotin plus chemotherapy may be a feasible frontline option for...
Conference Coverage
Drug can prevent chemo-induced nausea, vomiting
Credit: Rhoda Baer MADRID—A small molecule called rolapitant can prevent nausea and vomiting in patients receiving cisplatin-based chemotherapy,...
Conference Coverage
Rivaroxaban rivals standard for VTE in cancer
Credit: CDC MADRID—A pooled analysis of 2 studies suggests rivaroxaban prevents recurrent venous thromboembolism (VTE) in cancer patients as...
Conference Coverage
FDA approves cancer drugs faster, study shows
MADRID—The US Food and Drug Administration (FDA) tends to approve cancer drugs faster than Health Canada and the European Medicines Agency (EMA),...